title: Merits of a new drug trial for ALS?
authors.forename: Ettore
authors.initials: E
authors.lastname: Beghi
authors.forename: Caterina
authors.initials: C
authors.lastname: Bendotti
authors.forename: Tiziana
authors.initials: T
authors.lastname: Mennini
mesh_terms: D027322:Amino Acid Transport System X-AG / Q000096:biosynthesis; D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001692:Biological Transport / Q000187:drug effects; D002443:Ceftriaxone / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D018698:Glutamic Acid / Q000378:metabolism; D006801:Humans; D051381:Rats; D013116:Spinal Cord / Q000187:drug effects / Q000378:metabolism
chemical_list: D027322:Amino Acid Transport System X-AG; D000900:Anti-Bacterial Agents; D018698:Glutamic Acid; D002443:Ceftriaxone